Sign in

CIK 0000879407

  • Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
460408024
Phone
+1 626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 4 Grant or award General Counsel acquired 30,000 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4/A Open-market buy President and CEO bought 16,000 shares at $6.32 ($101,120)
  4. 4 Open-market buy President and CEO bought 16,000 shares at $6.32 ($101,120)
  5. 4 Open-market sale Director sold 2,500 shares at $14.70 ($36,749)
  6. 4 Open-market sale Chief Scientific Officer sold 15,000 shares at $15.02 ($225,350)
  7. 4 Open-market sale Director sold 2,000 shares at $15.24 ($30,480)
  8. 4 Open-market sale Director sold 5,000 shares at $13.90 ($69,501)
  9. 4 Open-market sale CFO sold 40,000 shares at $14.02 ($560,860)
  10. 4 Open-market sale Director sold 22,000 shares at $14.32 ($315,005)
  11. 4 Open-market sale CFO sold 16,000 shares at $18.77 ($300,290)
  12. 4 Open-market sale Director sold 3,148 shares at $15.98 ($50,296)
  13. 4 Grant or award Director acquired 15,000 shares (grant or award)
  14. 4 Grant or award Director acquired 15,000 shares (grant or award)
  15. 4 Grant or award Director acquired 20,000 shares (grant or award)
  16. 4 Grant or award Chief Operating Officer acquired 125,000 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 210,000 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award CFO acquired 70,000 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 17 of 25 · 497 filings